Monique Vogel

Title: Monique Vogel: Innovator in Antigen Binding Structures

Introduction

Monique Vogel is a prominent inventor based in Lausanne, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that can form antigen binding structures. With a total of five patents to her name, her work has the potential to impact pharmaceutical and diagnostic applications.

Latest Patents

Monique Vogel's latest patents focus on polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens. These patents detail the DNA encoding these polypeptides and the processes for their preparation and use. The polypeptides, which are Fab fragments, may be utilized directly as active ingredients in pharmaceutical and diagnostic compositions. Furthermore, the Fab fragments and their DNA sequences can be employed in the preparation of complete recombinant Anti-Rhesus D antibodies, making them useful in various medical applications.

Career Highlights

Throughout her career, Monique has worked with notable companies such as ZLB Behring AG and Nestec S.A. Her experience in these organizations has allowed her to refine her expertise in biotechnology and contribute to innovative solutions in the field.

Collaborations

Monique Vogel has collaborated with esteemed colleagues, including Beda Stadler and Andreas Morell. These partnerships have fostered a collaborative environment that enhances the development of her groundbreaking work.

Conclusion

Monique Vogel's contributions to the field of biotechnology, particularly in the area of antigen binding structures, demonstrate her innovative spirit and dedication to advancing medical science. Her patents and collaborations highlight her role as a key figure in the development of new therapeutic solutions.